Order Article Reprints

Gilham D, Wasiak S, Rakai BD, Fu L, Tsujikawa LM, Sarsons CD, Carestia A, Lebioda K, Johansson JO, Sweeney M, et al. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 2023; 11(6):1663. https://doi.org/10.3390/biomedicines11061663

Gilham, Dean, Sylwia Wasiak, Brooke D. Rakai, Li Fu, Laura M. Tsujikawa, Christopher D. Sarsons, Agostina Carestia, Kenneth Lebioda, Jan O. Johansson, Michael Sweeney, and et al. 2023. "Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment" Biomedicines 11, no. 6: 1663. https://doi.org/10.3390/biomedicines11061663

Gilham, D., Wasiak, S., Rakai, B. D., Fu, L., Tsujikawa, L. M., Sarsons, C. D., Carestia, A., Lebioda, K., Johansson, J. O., Sweeney, M., Kalantar-Zadeh, K., & Kulikowski, E. (2023). Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines, 11(6), 1663. https://doi.org/10.3390/biomedicines11061663